ECEMX
Price
$14.25
Change
-$0.20 (-1.38%)
Updated
Dec 18 closing price
FNWFX
Price
$80.67
Change
-$1.85 (-2.24%)
Updated
Dec 18 closing price
Ad is loading...

ECEMX vs FNWFX

Header iconECEMX vs FNWFX Comparison
Open Charts ECEMX vs FNWFXBanner chart's image
Parametric Emerging Markets C
Price$14.25
Change-$0.20 (-1.38%)
VolumeN/A
CapitalizationN/A
American Funds New World F3
Price$80.67
Change-$1.85 (-2.24%)
VolumeN/A
CapitalizationN/A
ECEMX vs FNWFX Comparison Chart
Loading...
View a ticker or compare two or three
VS
ECEMX vs. FNWFX commentary
Dec 19, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ECEMX is a Buy and FNWFX is a Buy.

FUNDAMENTALS
Fundamentals
FNWFX has more cash in the bank: 64B vs. ECEMX (182M). FNWFX pays higher dividends than ECEMX: FNWFX (1.56) vs ECEMX (1.31). ECEMX was incepted earlier than FNWFX: ECEMX (18 years) vs FNWFX (8 years). FNWFX is a more actively managed with annual turnover of: 32.00 vs. ECEMX (5.00). ECEMX has a lower initial minimum investment than FNWFX: ECEMX (1000) vs FNWFX (1000000). FNWFX annual gain was more profitable for investors over the last year : 12.00 vs. ECEMX (8.40). FNWFX return over 5 years is better than : 16.03 vs. ECEMX (6.20).
ECEMXFNWFXECEMX / FNWFX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence18 years8 years-
Gain YTD6.32810.02763%
Front LoadN/AN/A-
Min. Initial Investment100010000000%
Min. Initial Investment IRA1000N/A-
Net Assets182M64B0%
Annual Yield % from dividends1.311.5684%
Returns for 1 year8.4012.0070%
Returns for 3 years1.950.71275%
Returns for 5 years6.2016.0339%
Returns for 10 years10.93N/A-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
BRC75.93-0.76
-0.99%
Brady Corp
GEN29.38-0.35
-1.18%
Gen Digital
SACH1.24-0.03
-2.36%
Sachem Capital Corp
NN17.55-0.45
-2.50%
NextNav
CANF1.42-0.09
-5.96%
Can-Fite BioPharma Ltd